United Kingdom

Five Prime Therapeutics Inc (FPRX.OQ)

FPRX.OQ on NASDAQ Stock Exchange Global Select Market

3:04pm GMT
Change (% chg)

$-0.33 (-2.74%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Lewis Williams

68 2018 Executive Chairman of the Board

Aron Knickerbocker

48 2018 President, Chief Executive Officer, Chief Operating Officer, Director

David Smith

58 2018 Chief Executive Officer, Chief Financial Officer, Principal Accounting Officer, Principal Financial Officer

Bryan Irving

54 2018 Executive Vice President, Chief Scientific Officer

Kevin Baker

57 2016 Senior Vice President, Development Sciences